ArticleWorld journal of surgical oncology2022

Downregulation of B3GNT6 is a predictor of poor outcomes in patients with colorectal cancer.

Shihan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.